Ann: Fourth Midkine Symposium to be held in Budapest-CDY.AX, page-73

No probs  Osi... we will all get it soon enough. I have no qualms waiting as I am very happy with the work ethic, strategy and execution of Cellmid Management.

Also took the opp to top up a little more this last week pre conference noting the comments below from the recent strategic update.

"three areas, fibrosis, cancer and chronic heart disease, which are expected to be best commercialised through the new corporate structure.".

And this is just the therapeutic area alone.

http://www.pharmatelevision.com/SearchResults.aspx?K=cellmid

I expect the previous interviews of 2012 will soon be updated with the 2016 versions.

GLTA